Hamps Bio Limited board of directors approved remuneration increases for its Chairman and Managing Director, Whole Time Director, Chief Financial Officer, and a director during a meeting held on September 9, 2026. The decisions were made based on recommendations from the Nomination and Remuneration committee.

The corporate governance move affects key leadership roles within the Gujarat-based chemical manufacturer. The board meeting commenced at 5:00 pm and concluded at 5:45 pm at the company's corporate office.

Remuneration Approvals

The board considered and approved the following changes to executive compensation:

• Increase in remuneration for Mr. Herrik Mountbaton Shah, Chairman and Managing Director (DIN: 01052316)
• Increase in remuneration for Mr. Shrenikkumar Mountkumar Shah, Whole Time Director (DIN: 00973690)
• Increase in remuneration for Mrs. Mitali Shrenikkumar Shah, Chief Financial Officer
• Approval of remuneration for Mrs. Pallavi Herrik Shah, Director (DIN: 10418931)

All approvals followed recommendations received from the Nomination and Remuneration committee.

Regulatory Disclosure

The company issued this disclosure pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The filing was signed by Ravi Baheti, Company Secretary & Compliance Officer.

Hamps Bio operates manufacturing units in Ankleshwar and Surat, Gujarat.

Hamps Bio Limited has scheduled its 19th Annual General Meeting (AGM) for Wednesday, September 9, 2026, at 12:00 pm. The meeting will be held at the company’s registered office located at 2900/112, G.I.D.C., near Atul Limited, Bharuch, Ankleshwar, Gujarat.

The agenda for the meeting includes ordinary business such as the adoption of the audited standalone and consolidated financial statements for the fiscal year ended March 31, 2026. Additionally, shareholders will consider the re-appointment of Mrs. Pallavi Herrik Shah as a director, who retires by rotation and is eligible for re-appointment.

Special Resolution: Registered Office Shift

A key item on the agenda is a special resolution to approve the shifting of the company’s registered office from Ankleshwar to Surat. Both locations are within the state of Gujarat and under the jurisdiction of the same Registrar of Companies, Ahmedabad.

The Board of Directors stated that the move aims to carry on business more economically and efficiently with better operational convenience. The shift requires member approval via a special resolution pursuant to Section 12 of the Companies Act, 2013.

Director Re-appointment Details

Mrs. Pallavi Herrik Shah, currently serving as a director, seeks re-appointment. She holds a Bachelor of Pharmacy degree from Pune University (2002) and has expertise in administrative management and pharma/FMCG team analysis. As per disclosures, she holds 294,714 shares in the company. She is related to Mr. Herrik Mountbaton Shah (Chairman and Managing Director) and Mr. Shrenikkumar Mountkumar Shah (Director).

E-Voting and Logistics

Remote e-voting will commence on Sunday, September 6, 2026, at 9:00 am and conclude on Tuesday, September 8, 2026, at 5:00 pm. The record date for voting eligibility is Friday, September 3, 2026. Shareholders holding securities in demat mode can vote through their depository participants or directly via the Bigshare e-voting platform. Physical shareholders must use their folio numbers for login credentials.